A novel sacral neuromodulation protocol is associated with reduction in removal for device infection

ConclusionsUtilization of a novel SNM infection protocol tailored to a patient ’s preoperative MRSA colonization is associated with a reduction in the overall incidence of explant for device infection while avoiding prolonged postoperative antibiotic regimens.Clinical trial registrationThe study was initiated prior to January 18, 2017 and does not meet the definition of an applicable clinical trial (ACT) as defined in section 402 (J) of the US PHS Act.
Source: International Urogynecology Journal - Category: OBGYN Source Type: research